Search

Your search keyword '"Zer, A."' showing total 4,495 results

Search Constraints

Start Over You searched for: Author "Zer, A." Remove constraint Author: "Zer, A."
4,495 results on '"Zer, A."'

Search Results

251. Catalyst for change: future of DEI in academia

255. Systematic Transmission Electron Microscopy‐Based Identification and 3D Reconstruction of Cellular Degradation Machinery

256. Abstract PD15-01: PD15-01 AXILLARY NODAL RECURRENCE IS RARE IN PATIENTS WITH NODE-POSITIVE BREAST CANCER UNDERGOING SLNB FOLLOWING NEOADJUVANT CHEMOTHERAPY : EARLY RESULTS OF THE NEOSENTITURK-TRIAL/MF-18-03

257. PP01.17 Sotorasib in Advanced KRAS p.G12C–Mutated NSCLC with Treated or Untreated Brain Metastases: Safety and Efficacy Data from the Global Expanded Access Program (EAP)

259. The examination of the quotient of numerical semigroup with RF-matrices

260. Serial Block Face‐Scanning Electron Microscopy as a Burgeoning Technology

261. In the Age of Machine Learning Cryo‐EM Research is Still Necessary: A Path toward Precision Medicine

262. Ablation of Sam50 is associated with fragmentation and alterations in metabolism in human myotubes

263. Creating Optimal Conditions for OPA1 isoforms by Western Blot in Muscle Tissue

264. Components of Isolated Skeletal Muscle Differentiated Through Antibody Validation

265. Optimizing In Situ Proximity Ligation Assays for Mitochondria, ER, or MERC Markers in Skeletal Muscle Tissue and Cells

267. Does metabolic water control the isotopic composition of water in microbial cells?

268. Defining Mitochondrial Cristae Morphology Changes Induced by Aging in Brown Adipose Tissue

269. Using quotients as a mentor to facilitate the success of underrepresented trainees

270. A Comprehensive Approach to Sample Preparation for Electron Microscopy and the Assessment of Mitochondrial Morphology in Tissue and Cultured Cells

272. Arterial and Venous Thromboembolism in ALK-Rearrangement-Positive Non-small Cell Lung Cancer: A Population-Based Cohort Study

274. Data from Use of Expansion Cohorts in Phase I Trials and Probability of Success in Phase II for 381 Anticancer Drugs

277. Over Expression of the Cyanobacterial Pgr5-Homologue Leads to Pseudoreversion in a Gene Coding for a Putative Esterase in Synechocystis 6803

278. Mechanisms Underlying the Risk to Develop Drug Addiction, Insights From Studies in Drosophila melanogaster

280. The effect of spin exchange interaction on protein structural stability

281. Nasal Mucociliary Clearance and Sinonasal Symptoms in Healthcare Professionals Wearing FFP3 Respirators: A Prospective Cross-Sectional Study

283. DRP1 mutations associated with EMPF1 encephalopathy alter mitochondrial membrane potential and metabolic programs

285. Multinational Analysis of Estimated Health Care Costs Related to Extended-Interval Fixed Dosing of Checkpoint Inhibitors

288. UNcommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-Life Practice in First-LiNe Setting (UNICORN)

289. Using quotients as a mentor to facilitate the success of underrepresented students

292. NEPTUNE: Phase 3 Study of First-Line Durvalumab Plus Tremelimumab in Patients With Metastatic NSCLC

293. Serotype distribution of

294. The Impact of Risk Cycles on Business Cycles: A Historical View

295. A novel decision-making tool for first-line treatment selection in metastatic non-small cell lung cancer based on plasma proteome profiling

296. Serotype distribution of Streptococcus pneumoniae and pneumococcal vaccine coverage in adults in Turkey between 2015 and 2018

299. A novel decision-making tool for first-line treatment selection in metastatic non-small cell lung cancer based on plasma proteome profiling

Catalog

Books, media, physical & digital resources